Biomarin Pharmaceutical INC BIOMA.../ US09061G1013 /
23/01/2024 00:00:00 | Var. - | Volume | Denaro06:00:06 | Lettera06:00:06 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
94.04USD | - | 14 Fatturato: - |
-Quantità in denaro: - | -Quantità in lettera: - | 15.98 bill.USD | - | 94.55 |
GlobeNewswire
16:40
UNH Investors Have Opportunity to Lead UnitedHealth Group Securities Fraud Lawsuit with the Schall L...
GlobeNewswire
16:30
SPT Investors Have Opportunity to Lead Sprout Social, Inc. Securities Fraud Lawsuit with the Schall ...
GlobeNewswire
16:20
NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall...
Newsfile Corp
16:18
Shift5 Supports Air Force Special Operations Command (AFSOC) In-Flight Cybersecurity and Maintenance...
GlobeNewswire
16:02
NP Digital Recognized in Campaign Global Agency of the Year Awards for Second Consecutive Year
Newsfile Corp
16:00
Evanesce to Present Revolutionary Molded Starch Technology at the 2024 Canadian Climate Investor Con...
GlobeNewswire
16:00
Within one week, Shanghai Hi- Dolphin COFE+ completed its Series A second round of financing
GlobeNewswire
15:47
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALLG, SQSP, VAPO on Behalf of Shareho...
GlobeNewswire
15:30
Mexico Pacific Announces Commitment to Social Investments in Sonora and Chihuahua
GlobeNewswire
15:15
Del Taco Continues Its Florida Expansion With New Location in Orlando-Metro Area